1. Home
  2. IVDA vs LGVN Comparison

IVDA vs LGVN Comparison

Compare IVDA & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iveda Solutions Inc.

IVDA

Iveda Solutions Inc.

HOLD

Current Price

$0.31

Market Cap

3.7M

Sector

Technology

ML Signal

HOLD

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$2.79

Market Cap

21.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IVDA
LGVN
Founded
2003
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
21.4M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
IVDA
LGVN
Price
$0.31
$2.79
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $3.00
AVG Volume (30 Days)
★ 363.2K
145.0K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.38
50.76
EPS
★ N/A
N/A
Revenue
★ $4,468,279.00
$709,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.81
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 132.98
N/A
52 Week Low
$0.21
$0.48
52 Week High
$2.24
$7.60

Technical Indicators

Market Signals
Indicator
IVDA
LGVN
Relative Strength Index (RSI) 50.94 40.53
Support Level $0.27 $0.61
Resistance Level $0.33 $7.45
Average True Range (ATR) 0.02 0.42
MACD 0.00 -0.58
Stochastic Oscillator 45.70 9.24

Price Performance

Historical Comparison
IVDA
LGVN

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products). Geographically, the company operates in USA and Taiwan, majority of its revenue is generated from Taiwan.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: